SLC2A2 Antibody

• Background:

  This gene encodes an integral plasma membrane glycoprotein of the liver, islet beta cells, intestine, and kidney epithelium. The encoded protein mediates facilitated bidirectional glucose transport. Because of its low affinity for glucose, it has been suggested as a glucose sensor. Mutations in this gene are associated with susceptibility to diseases, including Fanconi-Bickel syndrome and noninsulin-dependent diabetes mellitus (NIDDM) . Alternative splicing results in multiple transcript variants of this gene.

• NCBI Gene ID:

  6514

• Swiss Prot:

  P11168

• Host:

  Rabbit

• Reactivity:

  Human, Mouse, Rat

• Immunogen:

  A synthetic peptide corresponding to a sequence within amino acids 1-100 of human SLC2A2 (NP_000331.1) .

• Clonality:

  Polyclonal

• Conjugation:

  Unconjugated

• Type:

  Primary Antibodies

• Field of Research:

  Cancer, Cell Cycle, Signal Transduction, Stem Cell

• Purification:

  Affinity purification

• Positive Control:

  SW480

• Concentration:

  Batch dependent

• Buffer:

  PBS with 0.02% sodium azide, 50% glycerol, pH7.3.

• Modification:

  None

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  Store at -20˚ C. Avoid freeze / thaw cycles.

• Calculated Molecular Weight:

  Observed: 57kDa

• Fragment:

  IgG

• Symbol:

  SLC2A2

• Positive Control 2:

  THP-1

• Positive Control 3:

  Mouse liver

• Positive Control 4:

  Mouse kidney

• Positive Control 5:

  Rat liver

• NCBI Official Name:

  Solute carrier family 2 (facilitated glucose transporter), member 2

• NCBI Organism:

  Homo sapiens

• Other Product Names:

  SLC2A2, GLUT2

• Tested Applications:

  WB, IHC

• Physical Properties:

  Liquid